EVENTS:   Venezuela: Outlook and Market Implications - Jimena Blanco/Verisk Maplecroft & Eileen Gavin/Verisk Maplecroft - 09 Jan 26   Trump’s Venezuela Gamble Has Unleashed the Dogs of War - David Murrin/Global Forecaster - 13 Jan 26   The Rise of Electric Vehicles and Robotaxis - Paul Hodges/New Normal Consulting - 14 Jan 26   2026: The Year of the US Dollar - Thanos Papasavvas/ABP Invest - 15 Jan 26     ROADSHOWS: DM L/S Healthcare Ideas Based on Fundamental Analysis by Experienced Former Medical Professionals - Dr. Aaron Fletcher /Bios Research   •   San Francisco   11 - 14 Jan 26       US, European and Asian SELL / SHORT Ideas - Robert Prather /Vision Research   •     13 - 16 Jan 26       L/S US Retail and Restaurant Ideas - John Zolidis /Quo Vadis Capital   •   London   20 - 20 Jan 26      
DM L/S Healthcare Ideas Based on Fundamental Analysis by Experienced Former Medical Professionals

11 - 14 Jan 2026

San Francisco

Bios Research
Dr. Aaron Fletcher Dr. Aaron Fletcher Co-Founder & Managing Partner Dr. Aaron, Managing Partner & Co-Founder, has a PhD in Biochemistry from Colorado State University and is currently a visiting professor in Biochemistry and Cell Biology at Dallas Baptist University; he has been a consultant in the financial industry since 2006. The Bios’ research effort is composed of Aaron and three additional analysts. Each of the analysts have Masters’ in Public Health or PhDs from leading academic institutions.
US, European and Asian SELL / SHORT Ideas
13 - 14 Jan Hong Kong
Vision Research
Robert Prather Robert Prather President & Managing Member Robert previously worked as a Research Associate – Rider Investments (2004 – 2006), Assistant Portfolio Manager – WestAM (2001 – 2004) and as a Senior Associate – PricewaterhouseCoopers (1998– 2000)
L/S US Retail and Restaurant Ideas

20 - 20 Jan 2026

London

Quo Vadis Capital
John Zolidis John Zolidis Founder & President John has followed retail and restaurants as a senior analyst since 1999, mostly on the sell-side. He also managed money in a buy-side role at a long-short equity fund over 2013-2014. He was named in the Wall Street Journal’s Best on the Street list.
Buyside to Buyside Forum and Expert Calls across TMT, Consumer, Healthcare and Fintech

26 - 27 Jan 2026

London

Revelare Partners
Andrew Peters Andrew Peters Co-Founder & Managing Partner Andrew is a co-founder of Revelare Partners. He has more than 15 years of experience in sales, research development and sourcing investment ideas for institutional investors. Prior to Revelare, Andrew was the Managing Director of Sales at DeMatteo Research LLC from 2011 to 2023 working with the team to build and expand its client base. He began his career as an Institutional Salesperson at PCS Research Services in 2008. He received a B.A. in Financial Economics from the University of Rochester.